ISTH 2020 Congress
Platelet Disorders and von Willebrand Disease » HIT
Theme Navigation
Abstract Number: PB1432
A Challenging Case of Delayed-onset Refractory Heparin-induced Thrombocytopenia Complicated with Arterial Thrombosis
Abstract Number: PB1429
Addition of Exogenous Platelet Factor 4 in the Heparin Induced Platelet Activation (HIPA) Assay for the Detection of Pathogenic Heparin-induced Thrombocytopenia Antibodies
Abstract Number: PB1431
Anaphylactic Shock to Apixaban in a Patient Treated for Heparin-induced Thrombocytopenia (HIT)
Abstract Number: PB1414
Autoimmune Heparin-Induced Thrombocytopenia Successfully Treated using Direct Oral Anticoagulant and Intra-Venous Immunoglobulin
Abstract Number: PB1413
Characterization of Murine Monoclonal Anti-PF4/Polyanion Antibodies, as Potential Useful Tools for Studies on Typical and Autoimmune HIT
Abstract Number: PB1418
Comparison of Clinical Adverse Events during Empiric Therapy for Patients with Suspected HIT
Abstract Number: PB1423
Detection of Pathogenic Anti-platelet Factor 4 Antibodies by Impedance Spectroscopy
Abstract Number: PB1430
Effect of Synthetic Inhibitors on HIT Antigenic Complex – Therapeutic Approach Alternative to Anticoagulation
Abstract Number: PB1424
Evaluation of 4T Probability Scores, Heparin PF4 Antibody, and Serotonin Release Values in End Stage Renal Disease Patients in the Assessment of Heparin Induced Thrombocytopenia
Abstract Number: PB1409
Evaluation of Fondaparinux (Arixtra®) at a Large Academic Medical Center
Abstract Number: PB1428
First Performance Data of a New Latex Enhanced Immunoassay to Detect HIT Antibodies in Plasma Samples *
Abstract Number: PB1420
Heparin-Induced Thrombocytopenia in Intensive Care Patients with Extracorporeal Circulation
Abstract Number: PB1433
HIT Antibody-induced Aggregation of Breast Cancer Cells
Abstract Number: PB1425
Inhibition of 12-LOX with VLX-1005 Has Clinical Utility for Prevention and Intervention of HIT
Abstract Number: PB1416
Insights into Autoimmune Heparin-Induced Thrombocytopenia
Abstract Number: PB1415
Interaction of Unfractionated Heparin and Sulodexide with Functional Anti-Heparin Platelet Factor 4 Antibodies as Investigated in Platelet Aggregation Assays
Abstract Number: PB1427
Platelet Flow Cytometry in the Diagnosis of Heparin-induced Thrombocytopenia
Abstract Number: PB1412
Prospective Comparison of Two Specific IgG Immunoassays (HemosIL® AcuStar HIT IgG and HAT 45-G®) for the Biological Diagnosis of Heparin-Induced Thrombocytopenia: A Bayesian Approach
Abstract Number: PB1422
The Utility of a Platelet Count-Based Electronic Medical Record Alert to Facilitate Diagnosis of Heparin-Induced Thrombocytopenia
Abstract Number: PB1419
Therapeutic Plasma Exchange in the Pre-Operative Management of Acute HIT